The Food and Drug Administration (FDA) intends to award a sole source contract to the Reagan-Udall Foundation for the FDA (RUF) to support execution of its congressionally mandated regulatory mission across 16 project areas addressing high-priority regulatory science gaps and public health challenges. The work — spanning structured stakeholder engagement, independent scientific convening, and landscape research — is a prerequisite to FDA's ability to develop sound regulatory frameworks and fulfill statutory obligations.
\n\nEach project area targets a specific gap where FDA cannot act without the scientific foundation, stakeholder input, or evidence infrastructure this contract provides. The contract is framed as a high-value investment: the cost of inaction — measured in delayed regulatory frameworks, preventable harm, and eroded public trust — exceeds the cost of the engagement.
\n\nSee Attachment for Intent to Sole Source Posting
\n\nSee Attachment for Draft Statement of Work
","text":"The Food and Drug Administration (FDA) intends to award a sole source contract to the Reagan-Udall Foundation for the FDA (RUF) to support execution of its congressionally mandated regulatory mission across 16 project areas addressing high-priority regulatory science gaps and public health challenges. The work — spanning structured stakeholder engagement, independent scientific convening, and landscape research — is a prerequisite to FDA's ability to develop sound regulatory frameworks and fulfill statutory obligations.\n\nEach project area targets a specific gap where FDA cannot act without the scientific foundation, stakeholder input, or evidence infrastructure this contract provides. The contract is framed as a high-value investment: the cost of inaction — measured in delayed regulatory frameworks, preventable harm, and eroded public trust — exceeds the cost of the engagement.\n\nSee Attachment for Intent to Sole Source Posting\n\nSee Attachment for Draft Statement of Work","origin":"detail"},"notice_type":{"code":"s","label":"Special Notice"},"schema_version":1,"solicitation_number":"FDASSOC136354","place_of_performance":{"zip":"20993","city":{"name":"Silver Spring"},"state":{"code":"MD"},"country":{"code":"USA"}},"product_service_code":"R799"}],"due_at":"2026-09-21T17:30:00Z","due_date":"2026-09-21","closes_at":"2026-09-21T17:30:00Z","awardable":false,"dept_key":"d-075","dept_name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF","sub_key":"s-7524","sub_name":"FOOD AND DRUG ADMINISTRATION","office_key":"o-752401","office_name":"FDA NEGOTIATED CONTRACTS BRANCH","state":"MD","country":"USA","winner_key":null,"amount":null,"linked_awards":0,"cancelled":false,"archived":false,"updated_at":"2026-09-16T07:31:38.954589Z","principal_notice_id":"43375f32d074401ebb2bb3897fc0cad9","description":{"text":"The Food and Drug Administration (FDA) intends to award a sole source contract to the Reagan-Udall Foundation for the FDA (RUF) to support execution of its congressionally mandated regulatory mission across 16 project areas addressing high-priority regulatory science gaps and public health challenges. The work — spanning structured stakeholder engagement, independent scientific convening, and landscape research — is a prerequisite to FDA's ability to develop sound regulatory frameworks and fulfill statutory obligations.\n\nEach project area targets a specific gap where FDA cannot act without the scientific foundation, stakeholder input, or evidence infrastructure this contract provides. The contract is framed as a high-value investment: the cost of inaction — measured in delayed regulatory frameworks, preventable harm, and eroded public trust — exceeds the cost of the engagement.\n\nSee Attachment for Intent to Sole Source Posting\n\nSee Attachment for Draft Statement of Work","html":"The Food and Drug Administration (FDA) intends to award a sole source contract to the Reagan-Udall Foundation for the FDA (RUF) to support execution of its congressionally mandated regulatory mission across 16 project areas addressing high-priority regulatory science gaps and public health challenges. The work — spanning structured stakeholder engagement, independent scientific convening, and landscape research — is a prerequisite to FDA's ability to develop sound regulatory frameworks and fulfill statutory obligations.
\n\nEach project area targets a specific gap where FDA cannot act without the scientific foundation, stakeholder input, or evidence infrastructure this contract provides. The contract is framed as a high-value investment: the cost of inaction — measured in delayed regulatory frameworks, preventable harm, and eroded public trust — exceeds the cost of the engagement.
\n\nSee Attachment for Intent to Sole Source Posting
\n\nSee Attachment for Draft Statement of Work
","origin":"detail"},"contacts":[{"name":"Howard Yablon","role":"primary","email":"howard.yablon@fda.hhs.gov"},{"name":"Ian Weiss","role":"secondary","email":"ian.weiss@fda.hhs.gov"}],"place_of_performance":{"zip":"20993","city":{"name":"Silver Spring"},"state":{"code":"MD"},"country":{"code":"USA"}},"office_address":{"zip":"20857","city":"ROCKVILLE","state":"MD","country":"USA"},"naics_codes":["541618"],"award":null,"attachments":[{"resource_id":"d2282d46975947b7b710691cff63f551","name":"Intent to Sole Source DRAFT 9 14 2026 1152 AM.pdf","kind":"file","mime_type":".pdf","size_bytes":82065,"posted_at":"2026-09-14T17:20:40.418Z","export_controlled":false,"sha256":"5f8d760394f1844d082a0e555357596b3dfe1ecdd9e6025af050a04df405d4eb","url":"https://abierto.us/files/5f8d760394f1844d082a0e555357596b3dfe1ecdd9e6025af050a04df405d4eb/Intent%20to%20Sole%20Source%20DRAFT%209%2014%202026%201152%20AM.pdf","mirrored":true},{"resource_id":"f80357b7f5224372bb99b1470608b3a9","name":"STATEMENT OF WORK DRAFT 9 14 2026.pdf","kind":"file","mime_type":".pdf","size_bytes":497542,"posted_at":"2026-09-14T17:20:40.418Z","export_controlled":false,"sha256":"a82f918f1e2bfdad09626dbcc4d6d13452506181246f78b0019a47fac5b4474f","url":"https://abierto.us/files/a82f918f1e2bfdad09626dbcc4d6d13452506181246f78b0019a47fac5b4474f/STATEMENT%20OF%20WORK%20DRAFT%209%2014%202026.pdf","mirrored":true}],"awards":[],"related":[]}